| Previous close | 92.03 |
| Open | 92.03 |
| Bid | 0.00 |
| Ask | 0.00 |
| Strike | 520.00 |
| Expiry date | 2024-12-20 |
| Day's range | 92.03 - 92.03 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
BloombergDealmaker Paul Parker Joins Health VC Firm Flagship Pioneering
(Bloomberg) -- Paul Parker, a former mergers and acquisitions banker turned health-care executive, is joining Flagship Pioneering Inc., the investment firm that created Covid-vaccine maker Moderna Inc.Most Read from BloombergUrban Heat Stress Is Another Disparity in the World’s Most Unequal NationChicago’s $1 Billion Budget Hole Exacerbated by School TurmoilShould Evictions Be Banned After Hurricanes and Climate Disasters?From Cleveland to Chicago, NFL Teams Dream of Domed StadiumsSingapore Ends
ZacksTMO's New ICP-MS Systems Boost Trace Element Analysis: Stock to Gain?
Thermo Fisher introduces the iCAP MX Series ICP-MS to simplify trace elemental analysis.
ZacksShould You Continue to Hold TMO Stock in Your Portfolio?
Thermo Fisher advances in its growth strategy, supported by its wave of innovations. However, macroeconomic issues escalate expenses.
© 2024 Yahoo. All rights reserved.